Marks Gilbert Lynn Insider Trades

Insider Trading History

Track insider trading activity for Marks Gilbert Lynn. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $332k 79,084 shares
Last Trade
Apr 10, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.2k 3,775 shares
$2.97
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99.7k 23,742 shares
Last Trade
Mar 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$175k 44,769 shares
$3.91
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $0 0 shares
Last Trade
Mar 19, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$175k 44,769 shares
$3.91
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $85.7k 20,400 shares
Last Trade
Feb 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$21.2k 20,400 shares
$1.04
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $316k 75,309 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.2k 11,560 shares
$1.14
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $268k 63,749 shares
Last Trade
Oct 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.1k 10,367 shares
$1.26
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $224k 53,382 shares
Last Trade
Jul 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12.7k 11,875 shares
$1.07
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $80.3k 19,111 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.7k 19,111 shares
$1.19
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $174k 41,507 shares
Last Trade
Apr 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$11.7k 9,705 shares
$1.21
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $134k 31,802 shares
Last Trade
Dec 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$12k 8,972 shares
$1.34
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $271k 64,503 shares
Last Trade
Jun 19, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$129k 64,503 shares
$2.00
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $99.7k 23,742 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$140k 23,742 shares
$5.91
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $43.5k 10,362 shares
Last Trade
May 12, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$179k 10,362 shares
$17.28
$4.20
AN2 Therapeutics
AN2 Therapeutics ANTX
Director
Holding Value $95.9k 22,830 shares
Last Trade
Mar 24, 2022 Sale
No data
No data
$4.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up